MISSISSAUGA, ON, Nov. 10, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen ...
Becton, Dickinson and Company BDX, also popularly known as BD, recently received the Emergency Use Authorization (EUA) from the FDA for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results